步入被称作"比难更难"的2025年，国货美妆行业的"退场名单"持续拉长，巧迪尚惠、境生之源、椿山、帷幕……这些曾在细分赛道有过声量的品牌都"倒 下"了。 行业寒冬下，新品牌的生存土壤也愈发贫瘠，从孵化到落地的每一步，都更具挑战性。但越是艰难的时候，越能见证国货美妆的破局魄力。庆幸的是，我 们看到2025年以来，行业不仅没有陷入新品牌停滞期，反而迎来一轮布局热潮。 如，上美股份一口气推出3个新品牌，贝泰妮酝酿三年的祛痘品牌进入待推倒计时，珀莱雅则意欲通过海外并购剑指婴童、香水、男士护肤等空白赛道， 就连半亩花田、方里、橘朵等中腰部品牌的母公司，也纷纷推出第二品牌…… 种种动作意味着，这些在处于领先地位的国货美妆企业们，正集体按下子品牌加速键，一场多品牌矩阵的攻坚战已全面打响。 头部企业扎堆"练小号" 今年布局子品牌的国货美妆中，既包含登陆资本市场的上市公司，也不乏处于行业中腰部的企业代表。 上市公司"多条腿并行" 于上市公司而言，当主品牌竞争到了一定阶段，往往会面临增长瓶颈，加之，企业为了触达更多细分人群，也需要拓宽市场覆盖维度。 这时候，"多条腿并行"就成为上市公司摆脱主品牌依赖、构建多元竞争力的重要战略选择 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the strong performance of the retail and beauty sectors, with a focus on the growth potential of domestic brands in the beauty industry [6][44] - The medical beauty segment is expected to see new growth drivers from innovative products, while the cosmetics sector is benefiting from the rise of domestic brands and consumer trends towards self-care [6][44] Summary by Sections 1. Market Review - The beauty and personal care index rose by 6.84% in August 2025, ranking 15th among all primary industries, underperforming the broader market which saw a 7.97% increase [12][15] - In the medical beauty sector, notable stock performances in August included Meili Tianyuan Medical Health (+32.4%), Kedi (+31.7%), and Yisi Health (+22.7%) [16] - In the cosmetics sector, leading performers were Jiaheng Home (+55.4%), Shuiyang Co. (+36.3%), and Ruoyu Chen (+29.0%) [20] 2. Medical Beauty - Jinbo Biological's "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" received drug auxiliary material registration, marking a significant advancement in the medical field [26] - Longzi Co. plans to acquire 67.5% of Chongqing Milan Baiyu for 92.475 million yuan, with performance commitments ensuring net profits of at least 9.29 million yuan, 9.89 million yuan, and 11.83 million yuan from 2025 to 2027 [28] 3. Cosmetics - Proya plans to list in Hong Kong, potentially becoming the first A+H share beauty company, which would enhance its international business development [32] - Proya's investment in Huazhi Xiao will strengthen its position in the makeup sector, leveraging Huazhi Xiao's content operations and overseas channels [35] - The launch of the NAN beauty brand by Shangmei Co. represents a strategic move to enhance its presence in the mid-to-high-end market [40] 4. Investment Recommendations - The report recommends focusing on leading domestic beauty brands that are continuously evolving and capitalizing on high-growth segments [44] - Key recommendations include Shangmei Co., Maogeping, Proya, and Runben Co., with an emphasis on their strong market positions and growth potential [48]

Core Viewpoint - The main brand, Han Shu, is solidifying its leading position in the Douyin beauty sector and is experiencing rapid growth on other e-commerce platforms [1][2] Group 1: Brand Performance - Han Shu maintained the top position in Douyin beauty rankings for Chinese brands, achieving this for two consecutive years in 2023 and 2024, and has held this ranking every month in the first eight months of 2023 [1] - The brand's competitive strength is highlighted by proactive adjustments to its live broadcasting and self-broadcasting models amid increasing industry competition [1] - In addition to Douyin, Han Shu's GMV on platforms like Tmall, Vipshop, Pinduoduo, and Kuaishou grew by over 20% in the first half of the year, indicating effective multi-platform collaboration [1] Group 2: New Growth Drivers - The mid-to-high-end baby and child brand, Yi Ye, reported a 147% year-on-year revenue increase in the first half of the year, with its revenue share rising to 9.6%, establishing it as the company's second growth curve [2] - Yi Ye's expansion from baby skincare to a full range of efficacy skincare for ages 0-18 is expected to further enhance its growth potential, with a projected compound annual growth rate of around 60% over the next three years [2] - The launch of the new color cosmetics brand, NAN beauty, in mid-August, is expected to enrich the company's multi-brand matrix, supported by collaborations with top makeup artists and e-commerce experts [2] Group 3: Long-term Growth Potential - The company's multi-brand and multi-category strategy is becoming increasingly robust, with several new brands and product categories in development [2] - The success of the multi-brand approach is attributed to effective incentive and management mechanisms, including internal empowerment and a results-oriented culture, as well as an open attitude towards external collaborations [2] Group 4: Profit Forecast and Investment Recommendation - The company's earnings forecast has been slightly adjusted, with expected earnings per share for 2025-2027 at 2.78, 3.55, and 4.37 RMB respectively [2] - A target price of 103.21 HKD is set for 2025, based on a 34x PE ratio, maintaining a "buy" rating [2]

Investment Rating - The report maintains a "Buy" rating for the company [5][10] Core Views - The main brand, Han Shu, has solidified its leading position in the Douyin beauty sector and is experiencing rapid growth on other e-commerce platforms, with a strong performance across multiple platforms [9] - The second growth curve has formed with the mid-to-high-end baby and child brand, Yi Ye, showing a significant revenue increase of 147% year-on-year, contributing to the company's growth [9] - The company launched a new high-end professional makeup brand, NAN beauty, which is expected to enhance its multi-brand strategy [9] - The company's multi-brand and multi-category layout is becoming increasingly mature, supported by effective management and incentive mechanisms [9] Financial Forecast and Investment Recommendations - The earnings per share (EPS) forecasts for 2025-2027 are adjusted to 2.78, 3.55, and 4.37 RMB respectively, with a target price of 103.21 HKD based on a 34x PE ratio for 2025 [4][10] - The company’s revenue is projected to grow significantly, with 2023 revenue at 4,191 million RMB and expected to reach 12,411 million RMB by 2027, reflecting a compound annual growth rate [4][10] - The gross margin is expected to remain stable around 75%, while the net profit margin is projected to improve from 11.0% in 2023 to 14.0% in 2027 [4][10]

Group 1 - The company reported a robust revenue growth of 17.29% year-on-year, achieving an operating income of 4.108 billion yuan in H1 2025 [1] - The net profit attributable to the parent company reached 524 million yuan, reflecting a significant increase of 30.65% year-on-year [1] - The gross margin for H1 2025 was 75.52%, a slight decrease of 0.99 percentage points, while the net profit margin improved by 1.74 percentage points to 13.52% [1] Group 2 - The main brand, Han Shu, generated revenue of 3.344 billion yuan in H1 2025, marking a 14.3% increase, with significant sales from the Hong Man Yao and X Peptide series [2] - The second brand, Newpage, saw a remarkable revenue growth of 146.5% year-on-year, reaching 397 million yuan, achieving its annual sales target for 2024 [2] - The company is actively enhancing its online sales strategy, with self-operated online channels generating 3.421 billion yuan in revenue, a 24.6% increase, and accounting for 83.3% of total revenue [2] Group 3 - The company is expected to achieve net profits of 1.025 billion yuan, 1.286 billion yuan, and 1.566 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 32, 26, and 21 [3]

Core Viewpoint - The company reported strong performance for H1 2025, with revenue of 4.11 billion yuan, a year-on-year increase of 17.3%, and a net profit of 560 million yuan, up 34.7% year-on-year, falling within the upper range of previous forecasts [1][2]. Revenue Breakdown - The multi-brand matrix continues to grow, with online revenue increasing by 20.1% year-on-year in H1 2025. By brand, revenue for 韩束, Newpage 一页, 红色小象, 一叶子, and other brands were 3.34 billion, 400 million, 160 million, 90 million, and 120 million yuan respectively, with year-on-year changes of +14.3%, +146.5%, -8.7%, -29.0%, and +2.9% [1]. - By channel, online and offline revenues were 3.81 billion and 270 million yuan respectively, with year-on-year changes of +20.1% and -10.6% [1]. - By segment, skincare, maternal and infant care, and other categories generated revenues of 3.42 billion, 560 million, and 130 million yuan respectively, with year-on-year changes of +10.2%, +65.0%, and +124.3% [1]. Profitability Metrics - The net profit margin increased by 1.7 percentage points year-on-year to 13.5%. The gross margin for H1 2025 was 75.5%, down 1 percentage point year-on-year, while the expense ratio was 63.2%, up 0.03 percentage points [2]. Brand Performance - The main brand 韩束 showed steady growth, maintaining the top position in beauty brands on Douyin, with GMV growth of +15.5% on Douyin and +26.1% on Tmall. Star products like 红蛮腰 sold over 15 million units, and the X 肽 series generated over 200 million yuan in sales [2]. - The Newpage 一页 brand rapidly expanded, targeting skincare products for ages 0-18, with significant sales during the 618 shopping festival, achieving GMV growth of +190% on Douyin and +106% on Tmall [2]. Brand Portfolio Expansion - The company has a robust pipeline of brands across multiple segments, including a sensitive skin care brand in collaboration with 昆药集团, a high-end skincare brand 聚光白, and a high-end anti-aging brand TAZU. Additionally, it is preparing to launch IP co-branded products in maternal and infant care and new hair care and makeup brands [3]. Profit Forecast and Investment Rating - The company is expected to achieve net profits of 1.11 billion, 1.41 billion, and 1.76 billion yuan for 2025-2027, representing year-on-year growth of 42.3%, 26.5%, and 24.8% respectively. The latest closing price corresponds to PE ratios of 30, 24, and 19 times for the respective years, maintaining a "buy" rating [3].

Core Viewpoint - Proya (603605.SH) has become the first domestic beauty brand to surpass 10 billion in revenue but is currently facing pressure from slowing performance [1][2] Financial Performance - In the first half of 2025, Proya reported revenue and net profit attributable to shareholders of 5.362 billion and 799 million respectively, representing year-on-year growth of 7.21% and 13.8% [1] - The second quarter showed a significant slowdown, with revenue of 3.003 billion, a year-on-year increase of only 6.49%, down over 30 percentage points compared to the same period in 2024 [1] - The main brand's revenue declined slightly by 0.08% to 3.979 billion in the first half of 2025, compared to a growth rate of 38% in the same period last year [5] Marketing Strategy - Proya has significantly increased its marketing expenditures, signing at least three top celebrities as brand ambassadors in 2025, which is more than the total of the past five years [1][9] - Marketing expenses reached 2.659 billion in the first half of 2025, a year-on-year increase of 13.64% [7] - The company is focusing on cost control, with operating costs down over 5% year-on-year to 1.427 billion [1][11] Competitive Landscape - Proya is set to compete with its peer, Shiseido's parent company, Up Beauty (2145.HK), which reported a revenue growth rate of 16% in the first half of 2025 [3][15] - Proya's market share is currently around 2%, indicating significant room for growth compared to mature markets [6] Future Plans - Proya is planning to list on the Hong Kong Stock Exchange, aiming to enhance its international strategy and financing capabilities [13][14] - The company has identified potential acquisition targets to boost its performance, with a goal of increasing its overall revenue to 35 billion from its own brands and 15 billion through acquisitions over the next decade [15][16]

Core Viewpoint - The company reported strong revenue and profit growth for the first half of 2025, with a 17.3% increase in revenue and a 30.6% increase in net profit attributable to shareholders, indicating robust operational performance and market positioning [1][2]. Financial Performance - The company achieved a revenue of 4.11 billion RMB and a net profit of 520 million RMB in the first half of 2025, with an EPS of 1.32 RMB [1]. - The gross margin decreased by 1 percentage point to 75.5%, while the expense ratio remained stable at 63.2% [2]. - Inventory increased by 7.2% year-on-year to 680 million RMB, with inventory turnover days decreasing by 5 days to 249 days [2]. - Operating net cash flow grew significantly by 77.5% to 390 million RMB [2]. Brand and Product Development - The main brand, Han Shu, maintained its leading position on the Douyin platform, ranking first among beauty brands and expanding its product line with new offerings [3]. - The company is actively pursuing a multi-brand strategy, launching new brands in various categories, including skincare, maternal and infant care, and cosmetics [3]. - New brands such as An Min You for sensitive skin and a high-end anti-aging brand TAZU are in development, alongside collaborations with well-known IPs for maternal and infant products [3]. Market Strategy and Outlook - The company is expected to benefit from its multi-brand strategy, which is anticipated to inject new growth momentum and enhance operational efficiency and profit margins [4]. - Profit forecasts for 2025, 2026, and 2027 have been adjusted upward to 1.16 billion RMB, 1.47 billion RMB, and 1.83 billion RMB, respectively, reflecting confidence in the company's growth trajectory [4].

Core Viewpoint - The article highlights the strong performance and growth potential of the beauty company, Shiseido Holdings (上美股份), driven by a multi-brand strategy, innovative product development, and a comprehensive sales channel approach, amidst a rising trend of young consumers prioritizing experience and value in their purchasing decisions [1][2][12]. Financial Performance - In the first half of 2025, Shiseido Holdings reported total revenue of approximately 4.108 billion RMB, a year-on-year increase of 17.3% [2] - The net profit reached about 555.6 million RMB, up 34.7% compared to the previous year, with a gross profit of approximately 3.102 billion RMB, reflecting a 15.8% increase [2] - The gross margin improved to 75.5%, marking a 1.7 percentage point increase from the previous period, indicating high-quality core business development [2] Multi-Brand Strategy - The company's strong performance is attributed to its deepening multi-brand strategy, with its main brand, Han Shu (韩束), achieving revenue of approximately 3.344 billion RMB, a 14.3% increase year-on-year [3] - Han Shu's star product, the Red Waist series, sold over 15 million units, establishing itself as a national skincare staple, while the X Peptide Super Frequency series surpassed 200 million RMB in sales [3][5] - The brand has successfully expanded into various product categories, achieving top sales in body lotion, shampoo, masks, and facial cleansers, transitioning from a facial skincare brand to a comprehensive care expert [3][5] Emerging Brands - The emerging brand, Newpage (一页), demonstrated significant growth, with revenue of 397 million RMB, a remarkable 146.5% increase year-on-year, and online sales exceeding the total for 2024 [5][6] - Newpage's flagship product, the Baby Comfort Cream, sold 330,000 units during the 618 shopping festival, ranking first in the Tmall and Douyin categories for baby creams [6] Sales Channels - The company has established a robust omnichannel sales strategy, with Han Shu ranking first in GMV on Douyin in the first half of 2025, contributing to significant growth across various e-commerce platforms [11] - This comprehensive sales ecosystem reflects the company's deep understanding of consumer behavior and market trends, enhancing brand loyalty and driving high potential across its product lines [11] Research and Development - Shiseido Holdings invested over 103 million RMB in R&D in the first half of 2025, a 31.7% increase year-on-year, resulting in nearly 200 patents and publications in global core journals [12][13] - The establishment of the "Han Shu Translational Medicine Fund" signifies the company's commitment to integrating academic and medical resources to accelerate product innovation [13] International Expansion - The company is actively pursuing international growth, particularly in Southeast Asia, aiming to enhance its global brand presence and transition from a "Chinese brand" to a "global brand" [14] - This strategic move is expected to open new growth avenues and increase the company's international influence [14] Conclusion - The impressive performance of Shiseido Holdings in the first half of 2025 is a result of its deepened multi-brand strategy, enhanced product capabilities, and optimized channel efficiency, positioning it as a key player in the domestic beauty market [14]

Core Viewpoint - The company aims to achieve a revenue target of 30 billion by 2030, but transitioning to high-end products is essential for success, as relying solely on low-priced skincare sets may not suffice [1] Group 1: New Brand Launch - The company has launched a new professional makeup brand, NAN beauty, in collaboration with renowned makeup artist Chun Nan, targeting young consumers aged 20-30 with mid-to-high-end positioning [1][3] - NAN beauty's initial product lineup includes items such as "CP Concealer Palette," "Beginner's Powder Cream," and "Smart Powder Cake," set to launch on September 9 on Douyin [3] Group 2: Market Trends and Competitors - The strategy of leveraging makeup artists' personal IPs to develop makeup brands is not unique, with successful examples like Mao Geping and Cai Tang, which have achieved significant revenue growth [4][5] - The company is following a trend where professional makeup artists enhance brand credibility and consumer connection, which is seen as an effective strategy for market expansion [5] Group 3: Financial Performance - The company reported a projected revenue of 40.9 to 41.1 billion for the first half of 2025, reflecting a year-on-year growth of 16.8% to 17.3%, with a significant net profit increase of 30.9% to 35.8% [6] - In 2024, the company achieved a total revenue of 70.44 billion, marking a 62.03% increase, with a net profit of 7.81 billion, up 69.42% [6][7] Group 4: Marketing Strategy - The company has adopted a low-price competition model, with its main skincare brand, Han Shu, generating over 80% of its revenue through aggressive marketing and promotional strategies [7][8] - Han Shu's sales on Douyin reached 67.49 billion in 2024, with a year-on-year growth exceeding 102%, indicating strong market presence [7] Group 5: High-End Market Strategy - The founder has set a goal of reaching 30 billion in revenue by 2030, acknowledging that low-priced products alone will not achieve this target, hence the focus on high-end product development [9] - The company plans to incubate 20 new brands between 2025 and 2027, with a focus on high-end offerings, including collaborations with scientists and celebrities [9][10] Group 6: Challenges in High-End Market - The company faces significant competition in the high-end beauty market from established brands like L'Oréal and Estée Lauder, making it challenging to establish a foothold [10][11] - The ability to tell compelling brand stories and create high-value cultural narratives will be crucial for the company's success in the high-end segment [11]